D-Wave Quantum: A Market-Driven Slide, a Non-Binding Korean Pact and a Japanese Prize That Still Isn't Revenue

D-Wave Quantum's shares fell 6.7% yesterday, caught in a broad technology selloff rather than any company-specific disclosure. The distinction matters more than the headline number: the pressure came from the market environment, while D-Wave's own financial results won't surface until November.

Sentiment, Not a Company Event

According to Reuters, Intel's results and outlook deepened worries about artificial intelligence spending and softer demand for computers. D-Wave slid alongside other quantum computing names as selling spread across the sector. Media reports also pointed to doubts about stretched technology valuations weighing on the wider market.

None of that pins the decline on a D-Wave announcement. Skepticism about AI budgets is a market backdrop, not fresh news about D-Wave's business — and a shared selloff doesn't make different technologies economically equivalent. Investors weighing the stock therefore need to keep two questions apart: how the market feels about tech, and how D-Wave itself is progressing. Both shape the share price, but they answer different things.

A Memorandum, Not a Contract

On the corporate side, D-Wave and LG CNS announced a non-binding letter of intent on Wednesday. The two plan to jointly develop and market quantum optimization for enterprise customers in South Korea and international markets, combining D-Wave's annealing technology with LG CNS's optimization and systems-integration expertise. Manufacturing, telecommunications, financial services and retail were named as target fields.

No contract value and no guaranteed revenue were disclosed. The agreement describes a possible collaboration, not a signed commercial deal or a rollout already under way. That gap is no semantic nicety — what counts for the financial picture is whether an intent eventually turns into actual business.

A Prize That Belongs to the Customer

Also on Wednesday, D-Wave reported a competitive win for its customer Shionogi. The Japanese drugmaker took the quality-of-life category at the NEDO Quantum Computing Challenge for research on quantum computing in drug discovery. According to D-Wave, the award carries a prize of ¥40 million to support further quantum-assisted drug research and included a peer-reviewed study using D-Wave's annealing technology.

That is a concrete application proof point. The prize money, however, backs Shionogi's research — it is not order revenue for D-Wave, and the win should not be read as a reported revenue contribution.

November 10 Is the Next Test

The next chance to read such application news alongside actual financials comes with the third-quarter 2026 report, which D-Wave plans to publish before the market opens on November 10, 2026, followed by a webcast.

Until then, the useful yardstick is the bindingness of each development: a research award, a cooperation intent and reported business results sit at different stages. A sector selloff tends to blur those lines — a sober read of the D-Wave story should hold them firmly in place.